For the year ending 2025-12-31, CVKD has $4,326,708 in assets. $1,587,982 in debts. $4,007,789 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 4,007,789 | |||
| Interest receivable | 5,096 | |||
| Prepaid expenses and other current assets | 200,140 | |||
| Deferred offering costs | 106,342 | |||
| Total current assets | 4,319,367 | |||
| Property, plant and equipment, net | 5,174 | |||
| Other assets | 2,167 | |||
| Total assets | 4,326,708 | |||
| Accounts payable | 650,663 | |||
| Accrued liabilities | 937,319 | |||
| Total current liabilities | 1,587,982 | |||
| Total liabilities | 1,587,982 | |||
| Common stock, 0.001 par value 75,000,000 shares authorized, 2,338,127 shares issued and outstanding as of december 31, 2025 1,782,486 shares issued and outstanding as of december 31, 2024 | 2,338 | |||
| Additional paid-in capital | 41,696,533 | |||
| Accumulated deficit | -38,960,145 | |||
| Total stockholders equity | 2,738,726 | |||
| Total liabilities and stockholders equity | 4,326,708 | |||
Cadrenal Therapeutics, Inc. (CVKD)
Cadrenal Therapeutics, Inc. (CVKD)